These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29671244)

  • 1. Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK.
    Abouchedid R; Gilks T; Dargan PI; Archer JRH; Wood DM
    J Med Toxicol; 2018 Jun; 14(2):134-143. PubMed ID: 29671244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
    Wu D; Fu L
    Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental versus theoretical log D
    Manchester KR; Maskell PD; Waters L
    Drug Test Anal; 2018 Mar; ():. PubMed ID: 29582576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Internet Snapshot Survey Assessing the sale of Synthetic Cannabinoid Receptor Agonists for use with Electronic Vaping Devices.
    Gould A; Dargan PI; Wood DM
    J Med Toxicol; 2024 Jun; ():. PubMed ID: 38839732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use.
    Marland V; Reid R; Brandon AM; Hill K; Cruickshanks F; McKenzie C; Norman C; Nic Daéid N; Menard H
    Drug Test Anal; 2024 May; 16(5):457-472. PubMed ID: 37587559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.
    Orsolini L; Corkery JM; Chiappini S; Guirguis A; Vento A; De Berardis D; Papanti D; Schifano F
    Curr Neuropharmacol; 2020; 18(9):809-837. PubMed ID: 31933443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: Pharmacokinetic data.
    Koch K; Auwärter V; Hermanns-Clausen M; Wilde M; Neukamm MA
    Drug Test Anal; 2018 Apr; ():. PubMed ID: 29637722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021.
    Papsun DM; Chan-Hosokawa A; Lamb ME; Logan B
    J Anal Toxicol; 2023 Nov; 47(8):668-679. PubMed ID: 37338191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real or fake? Sourcing and marketing of non-prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia.
    Grigg J; Peacock A; Lenton S; Salom C; Agramunt S; Thomas N; Lyons T; Sutherland R
    Drug Alcohol Rev; 2023 Sep; 42(6):1559-1565. PubMed ID: 37490407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus and reinforcing effects of diclazepam in rodents.
    Lee W; Lee JW; Kim S; Kim JM; Youn DH; Park SH; Kwon CH; Choi SO
    Pharmacol Biochem Behav; 2024 Feb; 235():173687. PubMed ID: 38016594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales.
    Hikin LJ; Coombes G; Rice-Davies K; Couchman L; Smith PR; Morley SR
    Forensic Sci Int; 2024 Jan; 354():111891. PubMed ID: 38043498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework.
    Berry K; Matheson C; Schofield J; Dumbrell J; Parkes T; Hill D; Kilonzo M; MacLennan G; Stewart D; Ritchie T; Turner M
    BMC Health Serv Res; 2023 Nov; 23(1):1205. PubMed ID: 37925423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical detoxification of bromazolam using diazepam: a case report.
    Buitenhuis D; Herdes DP; Verboeket SO
    J Addict Dis; 2024 Jul; ():1-6. PubMed ID: 38966947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Google Trends to monitor new psychoactive substance. Is there an added value?
    Batistic FK; Rhumorbarbe D; Lefrancois E; Tettey J; Raithelhuber M; Rossy Q; Morelato M
    Forensic Sci Int; 2021 Jul; 326():110918. PubMed ID: 34325112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.
    Dallery J; Raiff B
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):20-9. PubMed ID: 22149758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paying substance abusers in research studies: where does the money go?
    Festinger DS; Dugosh KL
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):43-8. PubMed ID: 22185328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educated Guesses and Other Ways to Address the Pharmacological Uncertainty of Designer Drugs: An Exploratory Study of Experimentation Through an Online Drug Forum.
    Berning M; Hardon A
    Contemp Drug Probl; 2016 Sep; 43(3):277-292. PubMed ID: 27721526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Death Involving 4-Fluoroethylphenidate (4F-EPH): Case Report, User Experiences, and Review of the Related Literature.
    Corkery JM; Schifano F
    Acad Forensic Pathol; 2022 Dec; 12(4):149-166. PubMed ID: 36545302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques.
    Mullin A; Scott M; Vaccaro G; Floresta G; Arillotta D; Catalani V; Corkery JM; Stair JL; Schifano F; Guirguis A
    Pharmacy (Basel); 2024 Jan; 12(1):. PubMed ID: 38251407
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.